| Sunday, June 23, 2013 - Thursday, June 27, 2013 |
| 01:00 AM Eastern Daylight Time |
The session will provide drug professionals with a deeper understanding of the key regulatory, clinical or quality issues that must be reviewed in buying a biopharmaceutical product or company and how to address those concerns in the due diligence phase.
When:
June 23, 2013 – June 27, 2013
8:30 am–12:45 pm ET
Where:
Boston, MA